| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/07/2012 | US20120141519 Reagents and methods for detecting influenza virus proteins |
| 06/07/2012 | US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/07/2012 | US20120141511 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 06/07/2012 | US20120141505 Cd19-ligand and use |
| 06/07/2012 | US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof |
| 06/07/2012 | US20120141486 Human monoclonal antibody |
| 06/07/2012 | US20120141482 Molecular complexes which modify immune responses |
| 06/07/2012 | US20120141470 T cell inhibitory receptor compositions and uses thereof |
| 06/07/2012 | US20120141460 Method for the production of variable domains |
| 06/07/2012 | US20120141399 Composition for Improving Skin Conditions Using Fetal Mesenchymal Stem Cells from Amniotic Fluid |
| 06/07/2012 | CA2820622A1 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
| 06/07/2012 | CA2819679A1 Compositions and methods for treating amyloid plaque associated symptoms |
| 06/07/2012 | CA2819356A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
| 06/07/2012 | CA2819187A1 Covalently dimerized bivalent binding agents |
| 06/06/2012 | EP2460823A1 A modified secretion system to increase expression of polypeptides in bacteria |
| 06/06/2012 | EP1618177B1 High mannose glucocerebrosidease and its production in plant culture |
| 06/06/2012 | CN1561343B Soluble T cell receptor |
| 06/06/2012 | CN102485903A Method for preparing biological active protein oligopeptide powder from deer placenta |
| 06/06/2012 | CN102485902A Method for producing daptomycin by fermentation |
| 06/06/2012 | CN102485879A Fermentation medium used for producing WF 11899A |
| 06/06/2012 | CN102485753A Human derived heavy chain variable region possessing human vascular endothelial growth factor binding activity |
| 06/06/2012 | CN101979656B Method for extracting hoof peptide |
| 06/06/2012 | CN101979652B Mactra quadrangularis protein polypeptide with antioxidant activity and preparation method and application thereof |
| 06/06/2012 | CN101974449B Lactobacillus plantarum and application thereof |
| 06/06/2012 | CN101864424B Method for efficient secretory expression and purification of recombinant 4Abeta15 in pichia pastoris |
| 06/06/2012 | CN101792766B Method for producing porcine growth hormones and special DNA fragment thereof |
| 06/06/2012 | CN101724677B Method for extracting collagen polypeptide and hydroxyapatite in fish scales by cooking hot extrusion |
| 06/06/2012 | CN101705241B Method for preparing recombined blue algae antiviral protein and application thereof |
| 06/06/2012 | CN101671392B Monoclonal antibody resisting hemocyanin of China prawns as well as preparation method and application thereof |
| 06/06/2012 | CN101525629B Gene engineering preparation method of bioactive peptide containing human alpha defensin 5 |
| 06/06/2012 | CN101503725B Technique for improving purity of diphtheria toxoid |
| 06/06/2012 | CN101284872B Antioxidation active peptides and method for preparing same |
| 06/06/2012 | CN101062405B Medicine for animals for treating and preventing avian influenza |
| 06/05/2012 | US8193414 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy |
| 06/05/2012 | US8193412 Precise breeding—simultaneous silencing |
| 06/05/2012 | US8193322 Methods for generating monovalent IgG |
| 06/05/2012 | US8193318 FcγRIIB specific antibodies and methods of use thereof |
| 06/05/2012 | US8192985 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 06/05/2012 | US8192965 Producing Itaconic acid in yeast using glycerol as the substrate |
| 06/05/2012 | US8192956 Hybrid genes and enzymes of glucanase and dextransucrase and processes for preparing isomalto-oligosaccharides or dextran using the same |
| 06/05/2012 | US8192953 Comprising tetranectin trimerising structural element (TTSE) capable of forming a stable complex with two other TTSEs; stability; used as a carrier of other chemical entities; drug delivery |
| 06/05/2012 | US8192952 Genetically encoded fluorescent coumarin amino acids |
| 06/05/2012 | US8192951 Industrial scale; by-product inhibition; drugs, immunogens, agriculture |
| 06/05/2012 | US8192932 Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase |
| 06/05/2012 | US8192740 Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 06/05/2012 | US8192739 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/05/2012 | US8192646 Inorganic particle conjugates |
| 06/05/2012 | CA2519113C Antibodies against insulin-like growth factor i receptor and uses thereof |
| 06/05/2012 | CA2490268C Protein glycosylation modification in pichia pastoris |
| 06/05/2012 | CA2446439C .delta.4-desaturase genes and uses thereof |
| 06/05/2012 | CA2435375C Mammalian tumor susceptibility gene products and their uses |
| 06/05/2012 | CA2233534C Manipulation of non-terminally differentiated cells using the notch pathway |
| 06/05/2012 | CA2187546C Rps2 gene and uses thereof |
| 06/05/2012 | CA1341630C Transformation vectors allowing expression of foreign polypeptide endotoxins in plants |
| 05/31/2012 | WO2012071422A2 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins |
| 05/31/2012 | WO2012071366A1 Stable preserved compositions if interferon-beta |
| 05/31/2012 | WO2012070975A1 Modified peptides with antiviral properties and method for the production thereof |
| 05/31/2012 | WO2012070964A1 Modified oligopeptides with anticancer properties and method for producing same |
| 05/31/2012 | WO2012042386A3 Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins |
| 05/31/2012 | US20120136141 Integrin Heterodimer And A Subunit Thereof |
| 05/31/2012 | US20120135913 Lysine compounds and their use in site- and chemoselective modification of peptides and proteins |
| 05/31/2012 | US20120135912 Polypeptide inhibitors of vla4 |
| 05/31/2012 | US20120135503 Minicell based delivery of biologically active compounds |
| 05/31/2012 | US20120135501 Recombinant poxvirus expressing homologous genes inserted |
| 05/31/2012 | US20120135499 Exo-endo cellulase fusion protein |
| 05/31/2012 | US20120135496 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof |
| 05/31/2012 | US20120135495 Neurotoxins with enhanced target specificity |
| 05/31/2012 | US20120135464 Stirrer system |
| 05/31/2012 | US20120135463 Rhamnose promoter expression system |
| 05/31/2012 | US20120135462 Polymer-Von Willebrand Factor-Conjugates |
| 05/31/2012 | US20120135461 Production of glycoproteins with reduced o-glycosylation comprising the use of an alpha-1,2-mannosidase |
| 05/31/2012 | US20120135460 Recombinant porcine chymotrypsin |
| 05/31/2012 | US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| 05/31/2012 | US20120135024 Neisseria meningitidis antigens and compositions |
| 05/31/2012 | US20120135019 Fviii peptides for immune tolerance induction and immunodiagnostics |
| 05/31/2012 | US20120135018 Erg monoclonal antibodies |
| 05/31/2012 | US20120135010 High affinity human antibodies to human il-4 receptor |
| 05/31/2012 | US20120135008 Methods and compositions for targeting polyubiquitin |
| 05/31/2012 | US20120135006 Ultra high affinity neutralizing antibodies |
| 05/31/2012 | US20120135005 ANTI-TNF-a ANTIBODIES AND THEIR USES |
| 05/31/2012 | US20120135003 Anti-ilt7 antibody |
| 05/31/2012 | US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 05/31/2012 | US20120134993 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination |
| 05/31/2012 | US20120134984 Molecules with extended half-lives and uses thereof |
| 05/31/2012 | US20120134961 Interferon-alpha (IFN-alpha) Fused Protein Having IFN-alpha and Cytoplasmic Transduction Peptide (CTP) |
| 05/31/2012 | CA2818689A1 Novel signal sequences to improve protein expression and secretion of recombinant enzymes and other proteins |
| 05/31/2012 | CA2817415A1 Antibodies that bind notum pectinacetylesterase |
| 05/30/2012 | EP2458013A1 Anti alpha v beta 6 antibodies and uses therof |
| 05/30/2012 | EP2458012A1 Anti alpha v beta 6 antibodies and uses thereof |
| 05/30/2012 | EP2457439A1 Transgenic non-human animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 05/30/2012 | EP2456871A2 Production of erythropoiesis stimulating protein using metal ions |
| 05/30/2012 | EP1870460B1 Methods of producing proteins having triple-helix structure |
| 05/30/2012 | EP1405079B1 Modulation of the interaction between evh1 domains |
| 05/30/2012 | CN1914322B Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same |
| 05/30/2012 | CN1902224B Process for purifying interferon beta |
| 05/30/2012 | CN1886506B Protein expressed in nk cell |
| 05/30/2012 | CN1878859B Novel brevibacillus choshinensis and process for producing protein with use of the microbe as host |
| 05/30/2012 | CN1798766B Humanized antibodies that recognize beta amyloid peptide |
| 05/30/2012 | CN102482701A Class I Anti-CEA antibodies and uses thereof |
| 05/30/2012 | CN102482700A 多肽和治疗方法 Polypeptides and methods of treatment |